Allworth Financial LP Bio N Tech Se Transaction History
Allworth Financial LP
- $17.3 Billion
- Q4 2024
A detailed history of Allworth Financial LP transactions in Bio N Tech Se stock. As of the latest transaction made, Allworth Financial LP holds 101 shares of BNTX stock, worth $12,500. This represents 0.0% of its overall portfolio holdings.
Number of Shares
101
Previous 78
29.49%
Holding current value
$12,500
Previous $9,000
22.22%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding BNTX
# of Institutions
360Shares Held
38.3MCall Options Held
2.45MPut Options Held
2.29M-
Baillie Gifford & CO8.22MShares$1.02 Billion0.74% of portfolio
-
Primecap Management CO Pasadena, CA4.52MShares$559 Million0.4% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.36MShares$540 Million2.05% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$235 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$224 Million0.88% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $30B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...